Cytogen (XKRX:217330) Ending Cash Position : ₩42,814 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cytogen Ending Cash Position?

Cytogen's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩42,814 Mil.

Cytogen's quarterly Ending Cash Position increased from Sep. 2023 (₩614 Mil) to Dec. 2023 (₩54,838 Mil) but then declined from Dec. 2023 (₩54,838 Mil) to Mar. 2024 (₩42,814 Mil).

Cytogen's annual Ending Cash Position declined from Dec. 2021 (₩30,288 Mil) to Dec. 2022 (₩15,878 Mil) but then increased from Dec. 2022 (₩15,878 Mil) to Dec. 2023 (₩54,838 Mil).

Cytogen Ending Cash Position Historical Data

The historical data trend for Cytogen's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytogen Ending Cash Position Chart

Cytogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

10,065.18

11,075.53

30,287.91

15,877.85

54,837.58

Cytogen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															11,859.78	6,241.74	614.40	54,837.58	42,813.75

Cytogen Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cytogen's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	15877.853	+	38959.726
	=	54,838

Cytogen's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	54837.58	+	-12023.831
	=	42,814

Cytogen Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Cytogen's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytogen (XKRX:217330) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

128, Beobwon-ro, Songpa-gu, A-8 Floor, SK V1 GL Metrocity, Seoul, KOR, 05854

Website

http://www.cytogenlab.com

Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

Cytogen (XKRX:217330) Headlines

No Headlines